AIM Immunotech
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
  • Science
    • Pipeline
    • Ampligen®
    • Immuno-Oncology
    • Immune Disorders
    • Viral Diseases
    • Orphan Drug Designation
    • Scientific Publications
  • Clinical Trials
    • Immuno-Oncology
    • Immune Disorders
    • Viral Diseases
  • Investors
    • Overview
    • Press Releases
    • Company Info
      • Profile
      • Management Team
    • Presentations
    • Events
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Board of Directors
      • Committee Composition
      • Stockholder Meeting
    • Email Alerts
    • Investor Contact
  • Contact Us
Select Page
  • Overview
  • Press Releases
  • Company Info
    • Profile
    • Management Team
  • Presentations
  • Events
  • Stock Information
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Board of Directors
    • Stockholder Meeting
    • Committee Composition
  • Email Alerts
  • Investor Contact
SEC Filings

Get Notified

Sign up to have the latest news and information delivered directly to your inbox!

Sign Up Now
Contact Us

AIM ImmunoTech
2117 SW Highway 484
Ocala, FL 34473
Phone: 352-448-7797
Fax: 352-480-4620
Email: info@AIMimmuno.com

Investor Relations Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
AIM@jtcir.com

©2023 AIM ImmunoTech     All Rights Reserved
  • Privacy Policy
  • Terms of Use